| Literature DB >> 35281923 |
Ke Li1,2,3,4, Xue-Qin Li1,3,4, Guang-Xin Li5, Lian-Jie Cui1,3,4, Xue-Mei Qin1,3,4, Zhen-Yu Li1,3,4, Yu-Guang Du2, Yue-Tao Liu1,3,4, Ai-Ping Li1,3,4, Xing-Yun Zhao1,3,4, Xin-Hui Fan1,3,4.
Abstract
Astragali Radix polysaccharides (APSs) have a wide range of biological activities. Our preliminary experiment showed that APS-Ⅱ (10 kDa) was the main immunologically active component of APSs. However, the characteristic structure related to activity of APS-Ⅱ needs further verification and clarification. In this study, APS-II was degraded by endo α-1,4-glucosidase. The degraded products with different degrees of polymerization [1-3 (P1), 3-6 (P2), 7-14 (P3), and 10-18 (P4)] were obtained using a polyacrylamide gel chromatography column. The structural features of the different products were characterized by HPGPC, monosaccharide composition, Fourier transform infrared spectrum, GC-MS, nuclear magnetic resonance, and UPLC-ESI-QTOF-MS analysis. Specific immune and non-specific immune cell tests were used to identify the most immunogenic fractions of the products. The backbone of P4 was speculated to be α-D-1,4-linked glucans and rich in C2 (25.34%) and C6 (34.54%) branches. Immune screening experiments indicated that the activity of P4 was better than that of APS-II and the other three components. In this research, the relationship between the structure of APS-Ⅱ and the immune activity from the degradation level of polysaccharides was studied, laying a foundation for the quality control and product development of APSs.Entities:
Keywords: APS-Ⅱ; enzymolysis; immune activity; structure analysis; structure-activity relationship
Year: 2022 PMID: 35281923 PMCID: PMC8913491 DOI: 10.3389/fphar.2022.839635
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1HPLC chromatogram of standard oligosaccharide samples (A), APOS (B), P1 (C), P2 (D), P3 (E), and P4 (F). 1–17: chromatographic peak of dextran with degree of polymerization of 2–18.
FIGURE 2Mixture monosaccharide standard of HPLC–UV chromatogram (A); (B–G) indicate the HPLC–UV chromatogram of APS-II, APOS, P1, P2, P3, and P4.1: PMP, 2: glucuronic acid, 3: rhamnose, 4: galacturonic acid, 5: glucose, 6: galactose, 7: arabinose.
Results of monosaccharide composition analysis of different saccharide components.
| Sugar component | Monosaccharide composition (molar ratio, %) | |||||
|---|---|---|---|---|---|---|
| Glucuronic acid | Rhamnose | Galacturonic acid | Glucose | Galactose | Arabinose | |
| APS-II | 0.32 | 0.56 | 1.70 | 79.85 | 3.86 | 13.71 |
| APOS | 0.25 | 0.30 | 1.58 | 93.70 | 1.40 | 2.76 |
| P1 | — | — | 0.33 | 98.18 | 0.20 | 1.29 |
| P2 | — | — | 0.48 | 98.38 | 0.56 | 0.58 |
| P3 | — | — | 0.29 | 98.88 | 0.02 | 0.81 |
| P4 | 0.24 | 0.63 | 3.86 | 85.67 | 3.88 | 5.72 |
Comparison of APS-II, APOS, and P1–P4 by FT–IR.
FIGURE 3FT-IR spectra of APS-II (A), APOS (B), P1 (C), P2 (D), P3 (E) and P4 (F).
Results of methylation analysis of different saccharide components.
| O-methylated alditol acetates | Linkage type | Mass fragment, m/z | Molar ratio % | ||||
|---|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | APOS | |||
| 2,3,5-Me3-Ara | Araf-(1→ | 75, 87, 88, 101, 111, 118, 127, 143, 145, 234 | — | — | 2.30 | 8.71 | 3.92 |
| 2,3,4,6-Me4-Gal | Galp-(1→ | 71, 87, 101, 111, 118, 127, 129, 145, 157, 205 | — | — | 2.76 | 6.65 | 3.14 |
| 3,5-Me2-Ara | →5)-Araf-(1→ | 59, 71, 87, 102, 118, 129, 189 | — | — | 0.92 | 1.05 | 8.64 |
| 2,3,4,6-Me4-Glc | Glcp-(1→ | 71, 87, 101, 102, 118, 129, 145, 161, 162, 205 | 18.45 | 21.23 | 13.82 | 3.01 | 14.14 |
| 2,3-Me2-Glc | →4,6)-Glcp (1→ | 73, 85, 87, 111, 127, 142, 171, 201, 233 | — | — | 5.53 | 34.54 | 9.69 |
| 2,6-Me2-Glc | →2,4)-Glcp (1→ | 71, 87, 99, 113, 130, 140, 173, 190, 233 | — | — | 6.45 | 25.34 | 2.88 |
| 4,6-Me2-Glc | →2,3)-Glcp (1→ | 45, 85, 87, 101, 115, 129, 161, 202, 232 | — | — | — | 4.52 | 6.28 |
| 2,3,6-Me3-Glc | →4)-Glcp-(1→ | 71, 87, 99, 117, 118, 129, 131, 141, 162, 173, 233 | 59.52 | 55.87 | 46.08 | 3.50 | 26.18 |
| 2,3,4-Me3-Glc | →6)-Glcp-(1→ | 71, 88, 99, 102, 118, 131, 173, 191, 233 | 8.33 | 6.14 | 5.07 | — | 2.09 |
| 6-Me-Gal | →2,3,4)-Galp (1→ | 45, 87, 99, 115, 129, 143, 157, 171, 185, 201, 231, 261 | — | — | — | 3.68 | 1.31 |
| 6-Me-Glc | →2,3,4)-Glcp (1→ | 87, 99, 115, 129, 157, 171, 185, 218, 231, 261 | 5.95 | 8.38 | 3.69 | 2.63 | 1.57 |
| 3-Me-Gal | →2,4,6)-Galp (1→ | 73, 85, 87, 99, 127, 130, 142, 159, 190, 201, 261 | — | — | 5.07 | 3.22 | 9.42 |
| 3-Me-Glc | →2,4,6)-Glcp (1→ | 73, 87, 99, 115, 130, 142, 159, 171, 190, 261 | 4.76 | 5.59 | 3.22 | 1.89 | 7.85 |
| 2-Me-Glc | →3,4,6)-Glcp (1→ | 73, 87, 97, 118, 139, 160, 171, 187, 202, 213, 231, 259 | 2.98 | 2.79 | 5.07 | 1.26 | 2.88 |
FIGURE 41H–NMR (A), 13C–NMR (B), HMBC (C), and HSQC (D) spectra of APOS.
Signals of chemical shifts in 1H and 13C NMR spectra of APOS.
| Residues | Chemical shifts (ppm) | |||||
|---|---|---|---|---|---|---|
| C1/H1 | C2/H2 | C3/H3 | C4/H4 | C5/H5 | C6/H6 | |
| Residue A, →2,4)- | 99.36 | 76.77 | 75.63 | 76.48 | 71.23 | 60.27 |
| 5.36 | 3.48 | 3.63 | 3.52 | 3.67 | 3.92 | |
| Residue B, →4)- | 99.65 | 71.54 | 73.20 | 76.89 | 71.61 | 60.32 |
| 5.36 | 3.56 | 3.76 | 3.24 | 3.89 | 3.70 | |
| Residue C, →4,6)- | 99.66 | 71.43 | 73.07 | 76.68 | 72.73 | 69.18 |
| 5.21 | 3.45 | 3.47 | 3.50 | 3.64 | 3.58 | |
| Residue D, | 99.23 | 72.60 | 71.35 | 71.06 | 71.17 | 60.60 |
| 4.65 | 3.54 | 3.82 | 3.26 | 3.68 | 3.84 | |
| Residue E, | 99.58 | 72.14 | 73.23 | 73.17 | 72.55 | 16.90 |
| — | — | — | — | — | 1.16 | |
FIGURE 5Mass spectra of two to nine sugars from APOS (A–H).
Mass spectrometric data of two to nine sugars in APOS.
| DP | tR/min | Molecular formula | [M-H]−, m/z | Mass fragment, m/z |
|---|---|---|---|---|
| 2 | 1.889 | C12H22O11 | 341 | 101, 113, 119, 120, 143, 161, 179, 221, 323 |
| 3 | 2.400 | C18H32O16 | 503 | 101, 113, 119, 143, 161, 179, 221, 263, 281, 341, 383 |
| 4 | 3.125 | C24H42O21 | 665 | 101, 113, 119, 143, 161, 179, 221, 263, 281, 323, 341, 383, 425, 545 |
| 5 | 4.068 | C30H52O26 | 827 | 101, 113, 119, 143, 161, 179, 221, 263, 281, 341, 383, 425, 443, 545, 587, 707 |
| 6 | 5.008 | C36H62O31 | 989 | 101, 113, 119, 143, 161, 179, 221, 263, 281, 341, 383, 425, 443, 503, 545, 587, 605, 665, 707, 749, 827, 869 |
| 7 | 5.986 | C42H72O36 | 1151 | 101, 113, 119, 143, 161, 179, 221, 263, 281, 341, 383, 425, 443, 503, 545, 587, 605, 665, 707, 749, 827, 869, 911, 989, 1031 |
| 8 | 7.019 | C48H82O41 | 1313 | 101, 161, 221, 263, 281, 341, 383, 425, 485, 503, 545, 587, 647, 707, 767, 809, 827, 869, 911, 929, 989, 1031, 1073, 1193 |
| 9 | 7.907 | C54H92O46 | 1475 | 113, 161, 179, 221, 263, 341, 383, 485, 545, 647, 707, 827, 869, 929, 989, 1031, 1073, 1193, 1235, 1355 |
FIGURE 6Possible repeating unit of APOS.
FIGURE 7Effects of different saccharide components on phagocytic activity (A), killing activity of mouse spleen NK cells (B), proliferation of B lymphocytes (C), proliferation of T lymphocytes (D), and IgG secretion of splenic lymphocytes (E) (n = 6, *p < 0.05, **p < 0.01, ***p < 0.001 versus APS-II; # p < 0.05, ## p < 0.01, ### p < 0.001 versus blank control group).